Michael McCaughan
When IMS Health released prescription data for January, a lot of people in Big Pharma companies were scratching their heads....
Big Pharma's Secret Weapon
Pharma companies say Medicare Part D is a simple trade: increased volume in exchange for decreased prices. Six months into the program, the deal is working out very well for manufacturers-but don't expect anyone to celebrate just yet.